A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus

This publication has 18 references indexed in Scilit:

• The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever in Iran
  Clinical Infectious Diseases, 2003
• Genetic Detection and Isolation ofCrimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia
  Emerging Infectious Diseases, 2002
• Hemorrhagic Fever Viruses as Biological Weapons
  JAMA, 2002
• Genetic Diversity of the M RNA Segment among Crimean-Congo Hemorrhagic Fever Virus Isolates in China
  Virology, 2002
• Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections
  Antiviral Research, 1994
• Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection
  Antiviral Research, 1993
• Treatment of lethal pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen
  Antiviral Research, 1993
• Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever
  The Lancet, 1990
• The Clinical Pathology of Crimean-Congo Hemorrhagic Fever
  Clinical Infectious Diseases, 1989
• Effects of ribamidine, a 3-carboxamidine derivative of ribavirin, on experimentally induced Phlebovirus infections
  Antiviral Research, 1988